Related Articles
More stories about SUD Innovations

Ozempic in Schizophrenia; Psychiatrist Talks Euthanasia; New Opioid Threat
(MedPage Today) -- In overweight, prediabetic schizophrenia patients on second-generation antipsychotics, semaglutide (Ozempic) significantly improved insulin sensitivity, fasting glucose, and weight. (Diabetes Care) Experts weighed in on whether...

Maker of Device To Treat Addiction Withdrawal Seeks Counties’ Opioid Settlement Cash
Some researchers and recovery advocates see the NET device as the latest in a series of products pitched as the solution to the addiction crisis that have been overhyped to capitalize on money from the opioid settlements.

Opinion: Anchorage’s addiction crisis demands more than stabilization
Overdose deaths may have leveled off, but gaps in treatment, housing and care continue to cost lives — and the city isn’t moving fast enough.

Dartmouth Health to open new addiction treatment center in Claremont
The New Hampshire Attorney General’s office required Dartmouth Health to fund and operate an addiction treatment center at the Claremont hospital for at least 10 years as a condition of the merger, which the Attorney General’s Office approved in 2024.

